Caricamento...
Efficacy and Safety of Vedolizumab in Ulcerative Colitis and Crohn’s Disease Patients Stratified by Age
INTRODUCTION: The efficacy and safety of vedolizumab, a gut-selective α(4)β(7) integrin antibody, were demonstrated in the GEMINI 1 and GEMINI 2 clinical trials of adults aged 18–80 years. We investigated the efficacy and safety of vedolizumab in patients stratified by age from the GEMINI trials. ME...
Salvato in:
| Pubblicato in: | Adv Ther |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer Healthcare
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5331094/ https://ncbi.nlm.nih.gov/pubmed/28070861 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-016-0467-6 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|